Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.970
-0.010 (-0.34%)
Aug 12, 2025, 5:35 PM CET
Elevation Oncology Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | - | 10.38 | 9.41 | 8.11 | 5.09 | 5.67 | Upgrade |
Depreciation & Amortization | - | 19.93 | 19.85 | 17.48 | 14.86 | 14.59 | Upgrade |
Other Amortization | - | 3.43 | 3.3 | 3.59 | 3.19 | 2.4 | Upgrade |
Loss (Gain) From Sale of Assets | - | 1.38 | 0.72 | 0.57 | 0.44 | 0.36 | Upgrade |
Asset Writedown & Restructuring Costs | - | 1 | 1 | 0.4 | - | - | Upgrade |
Loss (Gain) on Equity Investments | - | 0.12 | -0.98 | -1.59 | -0.09 | - | Upgrade |
Provision & Write-off of Bad Debts | - | 0.36 | -0.15 | -0.07 | 0.06 | 0.04 | Upgrade |
Other Operating Activities | - | -1.75 | -2.43 | -9.06 | -2.03 | -1.54 | Upgrade |
Change in Accounts Receivable | - | -1.23 | -4.73 | -3.08 | -1.75 | -1.39 | Upgrade |
Change in Inventory | - | -2.07 | -13.91 | -1.06 | -7.11 | -3 | Upgrade |
Change in Accounts Payable | - | -0.25 | 6.85 | 0.86 | 1.85 | 1.45 | Upgrade |
Change in Other Net Operating Assets | - | 0.04 | 0.21 | - | - | - | Upgrade |
Operating Cash Flow | - | 31.34 | 19.12 | 16.15 | 14.5 | 18.57 | Upgrade |
Operating Cash Flow Growth | - | 63.95% | 18.38% | 11.38% | -21.94% | 59.02% | Upgrade |
Capital Expenditures | - | -20.26 | -12.46 | -10.95 | -19.23 | -11.83 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0.11 | 0.11 | - | Upgrade |
Cash Acquisitions | - | - | - | -2 | -15 | -15 | Upgrade |
Sale (Purchase) of Intangibles | - | -0.52 | -0.31 | -0.41 | -0.54 | 0.32 | Upgrade |
Investment in Securities | - | -11.18 | -0.11 | 0.52 | -0.05 | -0.26 | Upgrade |
Investing Cash Flow | - | -31.97 | -12.88 | -12.72 | -34.7 | -26.77 | Upgrade |
Long-Term Debt Issued | - | 32.88 | 10.22 | 15.31 | 29.46 | 20.78 | Upgrade |
Total Debt Issued | - | 32.88 | 10.22 | 15.31 | 29.46 | 20.78 | Upgrade |
Long-Term Debt Repaid | - | -28.43 | -17.98 | -17.33 | -15.16 | -12.51 | Upgrade |
Total Debt Repaid | - | -28.43 | -17.98 | -17.33 | -15.16 | -12.51 | Upgrade |
Net Debt Issued (Repaid) | - | 4.45 | -7.77 | -2.02 | 14.3 | 8.27 | Upgrade |
Repurchase of Common Stock | - | -0 | -0.02 | -0.36 | -0.75 | -0.63 | Upgrade |
Common Dividends Paid | - | -0.03 | -0.04 | -0.05 | -0.06 | -0.09 | Upgrade |
Other Financing Activities | - | 1.17 | 0.67 | 0.39 | 0.18 | 2.06 | Upgrade |
Financing Cash Flow | - | 5.59 | -7.16 | -2.04 | 13.67 | 9.62 | Upgrade |
Net Cash Flow | - | 4.97 | -0.93 | 1.39 | -6.53 | 1.42 | Upgrade |
Free Cash Flow | - | 11.08 | 6.65 | 5.2 | -4.73 | 6.75 | Upgrade |
Free Cash Flow Growth | - | 66.51% | 27.90% | - | - | 15.65% | Upgrade |
Free Cash Flow Margin | - | 3.25% | 2.09% | 1.90% | -1.97% | 2.89% | Upgrade |
Free Cash Flow Per Share | - | 0.14 | 0.08 | 0.07 | -0.06 | 0.09 | Upgrade |
Cash Interest Paid | - | 1.96 | 1.23 | 1.04 | 0.88 | 0.99 | Upgrade |
Cash Income Tax Paid | - | -0.29 | 1.47 | 0.88 | 0.91 | 1.64 | Upgrade |
Levered Free Cash Flow | - | 4.16 | 4.58 | 8.98 | -18.25 | 16.95 | Upgrade |
Unlevered Free Cash Flow | - | 4.79 | 5.04 | 9.41 | -17.83 | 17.38 | Upgrade |
Change in Working Capital | - | -3.52 | -11.58 | -3.28 | -7.01 | -2.94 | Upgrade |
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.